The advent and evolution of stem cell technology has transformed what is understood about human biology and disease. The biomolecular characterization of stem cells, and their ability to produce virtually any cell in the body revealed new mechanisms of early human development. Beyond their contribution to basic sciences, they show significant promise in the field […]

DiaCarta Inc., a precision molecular diagnostics company with proprietary technologies for the development of novel liquid biopsy oncology tests, announced today the publication of a study in Nature Scientific Reports that demonstrates that DiaCarta’s cfDNA biomarker algorithm could function as a prognostic biomarker and efficacy predictor for non-small cell lung cancer (NSCLC) patients. DocWire News spoke with Mike Powell, PhD, […]

With so much focus on the Delta variant and breakthrough COVID, there is an escalating public health threat that requires our attention and action: Long COVID. It is on track to long outlast the pandemic, and its enduring impact on public health in America could be more profoundly devastating than we can currently predict. Formally […]